Authors:
Leibenguth, P
Le Guellec, C
Besnier, JM
Bastides, F
Mace, M
Gaudet, ML
Autret-Leca, E
Paintaud, G
Citation: P. Leibenguth et al., Therapeutic drug monitoring of HIV protease inhibitors using high-performance liquid chromatography with ultraviolet or photodiode array detection, THER DRUG M, 23(6), 2001, pp. 679-688
Authors:
Vaillant, L
Le Guellec, C
Jehl, F
Barruet, R
Sorensen, H
Roiron, R
Autret-Leca, E
Lorette, G
Citation: L. Vaillant et al., Comparative diffusion of fusidic acid, oxacillin, and pristinamycin in interstitial dermal fluid after repeated oral administration., ANN DER VEN, 127(1), 2000, pp. 33-39
Authors:
Guerin, C
Chevre, A
Dessirier, P
Poncet, T
Becquemin, MH
Dequin, PF
Le Guellec, C
Jacques, D
Fournier, G
Citation: C. Guerin et al., Inhaled fenoterol-ipratropium bromide in mechanically ventilated patients with chronic obstructive pulmonary disease, AM J R CRIT, 159(4), 1999, pp. 1036-1042
Authors:
Odoul, F
Le Guellec, C
Lamagnere, JP
Breilh, D
Saux, MC
Paintaud, G
Autret-Leca, E
Citation: F. Odoul et al., Prediction of methotrexate elimination after high dose infusion in children with acute lymphoblastic leukaemia using a population pharmacokinetic approach, FUN CL PHAR, 13(5), 1999, pp. 595-604
Citation: C. Le Guellec et al., Improved selectivity for high-performance liquid chromatographic determination of clonazepam in plasma of epileptic patients, J CHROMAT B, 719(1-2), 1998, pp. 227-233